It has shown promise in animal studies for promoting tissue healing, including in joints, by accelerating the repair of muscles, tendons, and ligaments, reducing inflammation, and potentially aiding in pain relief
Novel investigational Effects in Rat Spinal Cord Injuries: Recovery of the Definitive [PMID: 35678659] Laboratory literature summary: Novel investigational Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration
Typical Duration of Therapy The duration of BPC-157 therapy varies based on the conditions severity: Acute injuries or mild inflammation: 24 weeks Moderate injuries or post-surgical recovery: 48 weeks Chronic or systemic conditions: 812 weeks or longer For best outcomes, BPC-157 may be combined with TB-500, Thymosin Beta-4, or KPV peptides, along with targeted nutrition and physiologic optimization
In type one, we've got Sermorelin and Tesamorelin